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It is becoming more apparent in tissue engineering applications that fine temporal control of
multiple therapeutics is desirable to modulate progenitor cell fate and function. Herein, the
independent temporal control of the co-delivery of miR-148b and miR-21 mimic plasmonic
nanoparticle conjugates to induce osteogenic differentiation of human adipose stem cells (hASCs),
in a de novo fashion, is described. By applying a thermally labile retro-Diels–Alder caging
and linkage chemistry, these miRNAs can be triggered to de-cage serially with discrete control
of activation times. The method relies on illumination of the nanoparticles at their resonant
wavelengths to generate sufficient local heating and trigger the untethering of the Diels–Alder
cycloadduct. Characterization of the photothermal release using fluorophore-tagged miRNA
mimics in vitro is carried out with fluorescence measurements, second harmonic generation,
and confocal imaging. Osteogenesis of hASCs from the sequential co-delivery of miR-21 and
miR-148b mimics is assessed using xylenol orange and alizarin red staining of deposited minerals,
and quantitative polymerase chain reaction for gene expression of osteogenic markers. The results
demonstrate that sequential miRNA mimic activation results in upregulation of osteogenic markers
and mineralization relative to miR-148b alone, and co-activation of miR-148b and miR-21 at the
same time.

Author Manuscript
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1.

Introduction

Author Manuscript

Short noncoding RNA molecules participate in post-transcriptional regulation pathways and
have gained much attention in regulating gene expressions for a variety of treatments. In
particular, microRNAs (miRNA) offer promise in improving repair of tissue damage through
well-controlled regenerative processes.[1,2] These short RNA sequences associate with RNA
induced silencing complexes (RISC) and regulate mRNA localization, polyadenylation, and
translation.[3] Canonically, they negatively regulate gene expression through degradation
or translational inhibition, by binding to the 3′ untranslated region (3′UTR) of mRNA
transcripts.[3,4] Modulation of human mesenchymal stem cells (hMSCs), including adipose
derived (hASCs) and bone marrow stem cells (hBMSCs), using miRNAs has widely been
studied[5–7] with a keen focus on blueprinting therapies for bone defects and skeletal
reconstruction.

Author Manuscript

MicroRNA-148b was studied[8,9] and identified to upregulate alkaline phosphatase to
stimulate osteogenesis activity de novo in hBMSCs and hASCs. Li et al.[10] investigated
miR-148b in hASCs and reported noggin (NOG), a well-known bone morphogenetic protein
(BMP) gene repressor, as a direct gene target. miR-148b initiated downregulation of NOG
and promoted osteogenic differentiation through upregulation of BMP expression.
MicroRNA-21 is another widely studied RNA sequence, particularly in examining cell
proliferation of cancer cells and stem cells.[11,12] miR-21 was found to be overexpressed in
nonsmall cell lung cancer cells, and played a role in repressing phosphatase and tensin
homolog, a tumor suppressor, leading to lung cancer cell growth and invasion.[13] In
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contrast, overexpression in mouse embryonic stem cells was found to downregulate the
“stemness” and pluripotency of cells by directly targeting Sox2.[14]
To circumvent the issue of nonspecificity, a host of drug delivery systems has been
proposed,[15–18] from liposomal, and viral vectors, to proteins and nano-vehicles. While
their mechanisms are many, their purpose is identical: drug dormancy and inactivation
prior to reaching their intended target. From the aforementioned drug vehicles, plasmonic
nanoparticles have acquired considerable interest. Silver and gold nanoparticles have been
investigated for siRNA delivery, specifically for their release kinetics[19,20] as well as in the
delivery of miR-148b[9,21] to induce osteogenesis in hASCs.

Author Manuscript

While targeted delivery is an important concept for clinical and translational applications
of gene therapy systems, the ability to also co-deliver therapies sequentially and temporally
opens the door for a wide variety of effective treatments. The presented study demonstrates
the novel concept of delivering two different miRNA mimics, miR-21 and miR-148b,
on two separate nanoparticle vehicles, photothermally responsive gold (GNPs) and silver
nanoparticles (SNPs), in hASCs to demonstrate augmented osteogenesis.

2.
2.1.

Results and Discussion
Gold and Silver Nanoparticle Photothermal Release

Author Manuscript
Author Manuscript

Prior to investigating the osteogenic inductive ability of co-transfecting miR-21
and miR-148b, the photothermal release of the miRNA mimic molecules from the
surfaces of SNPs and GNPs was initially characterized. While gold nanoparticles were
commercially procured, the hydroxypropyl cellulose (HPC)-stabilized silver nanoparticles
were synthesized in house as previously described and characterized.[22,23] The latter
yielded particles with an average diameter size of 75.05 ± 0.65 nm, while the gold
nanoparticles’ average diameter size was 78.8 ± 2.85 nm. These nanoparticles were
used for all experiments while second harmonic generation measurements (SHG) were
conducted with a separate batch of each particle. As has been extensively published,
metallic particles at the nanoscale can exhibit plasmonic resonances. Noble metals, in
particular, demonstrate this phenomenon within visible light frequencies. These sub-100 nm
particles have demonstrated high transfection efficiency in mammalian cells,[24] and, in the
case of noble metal nanoparticles, the ability to respond to visible light frequencies upon
illumination. The latter occurs as a result of a polariton generated between the oscillating
conduction band electrons and positively charged lattice.[25] Upon illumination at resonant
wavelength of oscillation, these electrons enter an electron–hole pair excited state, which
results in electron–electron scattering as well as electron–lattice scattering. The extinction
spectra of both nanoparticles used in the present study are reported in Figure 1A,B, along
with their transmission electron microscope (TEM) images. The plasmon peak was observed
at 405–415 nm for SNPs and 551–557 nm for GNPs. As a result of this plasmonic response,
generation of localized heating on the nanoparticle surfaces can be achieved in what is
referred to as the photothermal effect. This has been explained by the metal’s ability
to absorb far-field radiation, generating enhanced near fields, with plasmonic resonances
decaying by re-emission of electrons, and producing hot electron–hole pairs via Landau
damping.[26,27] Heat dissipation into the local surroundings arises from electron–electron
Small. Author manuscript; available in PMC 2021 October 21.
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scattering between “hot” electrons and lower energy electrons, as well as electron–phonon
interactions that give rise to lattice energy losses.[25]

Author Manuscript

With any RNA delivery vehicle, a stable conjugation is crucial to protect the structure and
function of therapeutics against opsonization and RNase degradation. Characterization of
this system and its stability was described in our previous manuscript.[22] By conjugating
to the nanoparticle surface, we can enhance the stability of RNA and shield it from RNAse
degradation and lysozyme hydrolysis. Additionally, the 2’-O-methyl modified RNA mimics
used in the study aid in prolonging the lifetime of RNA in serum containing media.[28] For
effective therapeutic activity, however, a controlled and targeted mechanism for the release
of molecules is also significant. Early exposure to acidic environments in endo/lysosomal
structures within cells will mute nucleic acid molecules’ biological effects, requiring a
large deliverable dose to mitigate this loss. While there have been several advances made
in the design of nanoparticle systems, their release mechanisms are largely assumed or
neglected. To design a nanoparticle vehicle with targeted ability to decage and release
miRNA mimics, a thermally labile linker, responsive to the nanoparticles’ photothermal
phenomenon was developed that could cleave and release conjugated miRNA mimics at
localized temperatures greater than 60 °C.[22,29] The covalently bound linker was based on
Diels–Alder chemistry which relies on the cycloadduct formation between a diene molecule
and dienophile. The advantage this linker possesses is the ability to selectively release
conjugated miRNA upon photo-irradiation of the nanoparticle substrate at their plasmon
wavelength, generating adequate localized heat to initiate the retro-Diels–Alder reaction and
release the miRNA. This study is the first to our knowledge that demonstrates the proposed
delivery vehicle in a biological application.

Author Manuscript

A type of click chemistry, the Diels–Alder cycloaddition takes place between a diene and
dienophile possessing overlapping orbital energies (diene’s lowest unoccupied molecular
orbital and dienophile’s highest occupied molecular orbital), generating sigma bonds from
π bonds [4 + 2].[30–32] The result is a stable covalently bound linker capable of conjugating
molecular cargo to surfaces. In the present study, a cycloadduct between a furan group
and maleimide was prepared, with additional modifications on the terminal ends. The thiol
terminal group on the furan end allows for the facile linkage between the – SH group and
Ag and Au surfaces, as has been described.[33] On the maleimide terminal, a hexanoic acid
group was added which enabled the covalent crosslinking between carboxyl ends and the
5’ amine-modified miRNA mimics to yield a robust amide bond. At temperatures 60 °C
or higher, it was demonstrated that the retro-Diels–Alder reaction, i.e., the reversal of the
cycloadduct, could be triggered.[22,29] Using photo-activation, sufficient localized heat was
generated to thermally cleave the linker.

Author Manuscript

Different miRNA mimics with distinct fluorophores were attached to the SNPs and GNPs
using Diels–Alder chemistry and irradiated to quantify the photo-release. For each NP
system, 30 uL of 4uM miRNA mimics was added per mL of nanoparticle suspension.
Final measurements had shown that miRNA surface quantity on NPs after modification
and cleanup was approximately 9271 miRNA molecules per SNP, and 18512 molecules
per GNP. A packing rate of almost double that of SNPs was observed for GNPs. This
is likely due to the superior GNP surface stability and resistance to surface oxidation
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that may reduce the favorability of thiol (Au/Ag-SH) linkages in the case of silver. At
different light-emitting diode (LED) light energies, at their respective plasmon wavelengths,
the zeta potentials of the nanoparticle surfaces were measured and are shown in Figure
1C. To further investigate the extent of release at their plasmon wavelengths, fluorescence
measurements of the released miRNA in the supernatant were taken, upon irradiation at
530 and 405 nm with increasing incident light exposure. These results are presented in
Figure 1D. In these samples, miR-21 on SNPs were tagged with Cy3 molecules, while
miR-148b on GNPs were labeled with fluorescein amidites (FAM). As shown, photo-release
was achieved at each particle’s plasmonic wavelength, while almost no release was observed
upon reversal of the applied light wavelengths. Furthermore, at equal light energy outputs,
the SNPs exhibited much more robust de-caging than the GNPs. To investigate further,
the absorbance of the Diels–Alder adduct only was measured and is presented in Figure
S1 in the Supporting Information. From this data, high absorbance was observed at ≈400
nm with a discernable local maximum at around 450 nm. This suggests a possibly more
complex process involved in the photothermal response of SNPs on the retro-Diels–Alder
reaction, with likely a coupled phononic/thermal response and electron-ejection or photon
generating phenomenon triggering the untethering of the cycloadduct. This phenomenon of
“hot carriers” has been well described in photocatalytic reactions,[34,35] playing a role in
lowering the activation energy barriers in bonds adhered to the surface and has been shown
to be distinct from the typical photothermal effect. This relationship between the thermal and
nonthermal response was found to be synergistic and co-dependent, increasing super-linearly
with increased illumination. Experiments to confirm this are outside the scope of this study
but are recommended for future studies. However, the argument that the cycloadduct can
sever in response to direct 405 nm LED light alone seems unlikely, as a result of the
observed release profile for the GNP-FAM sample at 405 nm. The nonplasmon resonant
state of the GNPs at 405 nm led to little or no photo-release. Overall, the release trends in
Figure 1D suggest more effective release of the miRNA from SNPs than GNPs at shorter
light exposures, offering the ability to co-deliver small molecules at separate and distinct
intervals.

Author Manuscript
Author Manuscript

2.2.

SHG Measurement

Author Manuscript

SHG is a noninvasive, nondestructive, surface-sensitive, non-linear spectroscopy for
characterizing physical and chemical properties at colloidal nanoparticle interfaces.[36–39]
In the SHG process, two incident photons of frequency ω add coherently to generate a
third photon with a frequency of 2ω. SHG is dipole forbidden in centrosymmetric media,
like bulk solution, but can be generated at the surface of nanoparticles where the symmetry
is broken. Recently, SHG has been used as an accurate method to determine molecular
adsorption and chemical reactions at nanoparticle surfaces,[40,41] ion-transport processes
in liposomes,[42–44] and the release of oligonucleotides from the surface of plasmonic
nanoparticles.[19,20,22,45]
The release of miRNA from the surface of gold and silver plasmonic nanoparticles
was measured in real time using surface-specific SHG spectroscopy. Representative
SHG spectra, centered at 400 nm with a full-width half-maximum of approximately
4.5 nm, of SNP-miR-21 complex are shown in Figure 2A. The miRNA-functionalized
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nanoparticles have higher SHG intensities than the corresponding nanoparticles without
miRNA functionalization due to the increased surface charge density through the χ(3) effect,
in agreement with our previous results.[19,20,22,45] Upon irradiation at 400 nm, the SNP
absorbed energy at the plasmon resonance, leading to the cleaving of the linker and release
of miRNA mimic, resulting in a lower SHG intensity, as shown in Figure 2A. Similar results
are also obtained for GNP-miR-148b upon irradiation at 530 nm (Figure S2, Supporting
Information). These cleaving dynamics were caused by the photothermal response of the
plasmonic nanoparticles, by hot electrons generated from the plasmon resonance leading to
cleavage of the linker, or likely a combination of these two processes.[46,47]

Author Manuscript

The time-dependent SHG experiments for both sets of nanoparticles were analyzed using
power-dependent fits, with higher irradiation powers leading in faster and more complete
photothermal cleaving, as shown in Figure 2B,C. The experimentally obtained results were
fit to a pseudo first-order exponential function given by ESHG = A + B e−kt , where
k is the cleaving rate and A and B are proportionality constants. The values of the fit
parameters are summarized in Tables S1 and S2 in the Supporting Information. Figure
2D displays the obtained rate constants plotted as a function of laser power for the gold
and silver nanoparticles, with corresponding linear fits. The obtained slopes from the fits
are (0.007 ± 0.001) and (0.011 ± 0.001) s−1 mW−1 for the gold and silver nanoparticles,
respectively. Similarly, the obtained y-intercepts from the fits are (0.471 ± 0.166) and (0.366
± 0.147) s−1 for the gold and silver nanoparticles, respectively. The nonzero y-intercepts
are a result of small amount of cleaving caused by the 800 nm laser needed for the SHG
measurements. These experimental results indicate that the photothermal release of miRNA
mimic at the corresponding plasmon resonances was more efficient for silver nanoparticles,
as seen earlier in the fluorescence measurements. This result can be attributed to a higher
concentration of hot electron formation in silver nanoparticles leading to higher cleaving
efficiencies, although more research is needed to study this process in greater detail.
Additionally, control experiments show that the SNP-miR-21 complex has only minimal
cleaving upon irradiation with 530 nm, as displayed in Figure 2B. In contrast, the GNP
miR-148b complex has a greater amount of cleaving upon irradiation at 400 nm, as shown in
Figure 2C. The gold nanoparticle plasmon peak is centered near 530 nm; however, the gold
nanoparticles retain substantial absorption near 400 nm. This absorption at 400 nm can raise
the local temperature of the gold nanoparticle surface leading to the photothermal release of
miRNA and the corresponding decrease in the SHG intensity that was observed.

Author Manuscript
2.3.

In Vitro Photo-Release of GNPs and SNPs

Author Manuscript

To investigate the photothermal release of the Diels–Alder-linked and FAM-tagged
oligonucleotides in vitro between the two sets of nanoparticles, colocalization between
the nanoparticles and fluorescent molecules in the transfected cells were examined using
confocal microscopy. For all light irradiation experiments, cells were cultured in Opti-MEM
reduced serum media. This was due to the possibility of near-UV wavelengths generating
toxic photo-products and radical oxygen among amino acid components of Dulbecco’s
modified Eagle medium (DMEM).[48] At 405 nm, hASCs transfected with either SNP-FAM
or GNP-FAM were illuminated at 50 J of incident light energy, and 565 J at 530 nm.
Due to the observed toxic cellular response to the 405 nm LED light source, the 405 nm
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group was maintained at a much less intense exposure than the GNP samples to mitigate its
adverse effects. More importantly, release rates in Figure 1D revealed that 550–600 J was
needed for substantial thermal cleavage in GNP samples at 530 nm. For each nanoparticle
system, images were taken of nonilluminated samples (NA), samples irradiated at 405 nm
(50 J), and at 530 nm (565 J). These images are presented in Figures 3 and 4, for SNP and
GNP, respectively. The green fluorescein isothiocynate (FITC) channel was used to view
the FAM conjugated to the nanoparticles, while the blue and red channels were selected
to view SNPs and GNPs, respectively. The overlay images between the nanoparticles’ and
FAM channels are presented as a qualitative assay in determining release of the payload
upon photo-activation based on colocalization of the channels. In Figure 3, SNP-FAM 405
nm treated cells showed more intense and punctate spots of green that do not colocalize
with the blue pixels contributed by the silver nanoparticles’ plasmon scattering. Due to
fluorescence resonance energy transfer (FRET) during conjugation prior to release, the
optical scattering intensity of the nanoparticles is likely diminished as a result of the
proximally close fluorophore tag on the miRNA molecules. FRET phenomenon occurs as a
result of overlapping excitation and emission levels of two optically active molecules, and
close distance between the two. This is due to the energy decay from high energy electrons
to lower levels transferred to excite the electrons in the neighboring molecule, reducing the
effect of photoemission. From this, we anticipate the released sample of SNPs at 405 nm to
exhibit more intense blue signals as the scattering phenomenon is no longer weakened by
FRET. This is a result of the distance increase between the probes.[49]

Author Manuscript

The average calculated Mander’s colocalization coefficients were calculated and plotted in
Figure S5 in the Supporting Information but are summarized here: for the nonirradiated
SNP samples, 530 nm-irradiated, and 405 nm-irradiated samples were 0.723, 0.653, and
0.436, respectively. Among these groups, the 405 nm was the only statistically significant
group. The results indicate thermal release at the particles’ plasmon resonance wavelength,
as anticipated.

Author Manuscript

SNP-treated hASCs were also treated with Texas-Red-tagged transferrin endosomal staining,
to investigate the nanoparticle-miRNA conjugates ability to escape from the encapsulations
after endocytic uptake.[50,51] Those images along with the z-stack images are presented
in Figure S5 in the Supporting Information. Low to moderate amounts of colocalization
were found between the red-stained endosomes and green SNP-FAM molecules regardless
of illuminated state, suggesting clathrin-mediated endosomal encapsulation to be present
but limited. The transfection mechanism of metal nanoparticles has been demonstrated to
be nonspecific.[52] Receptor-mediated uptake as well as phagocytosis, macropinocytosis,
adhesion, and passive transport, has all been demonstrated to play a role in nanoparticle
entry into cells.[53] Whether one mechanism dominates over the others is largely dependent
on the particle’s size and shape, surface charge, and chemical moiety.[51,52,54]
In Figure 4, images of hASCs treated with GNP-FAM are represented. Once again, upon
inspection of the overlay channels between the FAM and GNPs, a greater degree of de
colocalization is observed in the 530 nm-irradiated sample, GNPs’ plasmonic resonant
wavelength. The average calculated Mander’s coefficients, plotted in Figure S5 in the
Supporting Information, for the nonirradiated, 405 nm-irradiated, and 530 nm-irradiated
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samples were 0.800, 0.790, and 0.543, respectively. Only the 530 nm group showed
statistical significance.
2.4.

Osteogenic Induction
Studies with MSCs suggest miR-21 plays a role in exiting stem cells from their G1-S-G2-M
cell cycle and toward nonspecific differentiation. Reports of miR-21 mimics promoting
osteogenic differentiation in hBMSCs by targeting the SMAD-7 gene a suppressant of the
TGF-β family,[55] and adipogenesis in hASCs via TGF-β/SMAD 3 signaling modulation,[56]
have been demonstrated. These results allude to the strong possibility of miR-21 acting to
promote differentiation toward the most probable and likely lineage associated with the cell
type; adipocytes for hASCs and osteoblasts for hBMSCs. It is, therefore, hypothesized that
it is possible to drive cells down a differentiation pathway with one post-transcriptional
regulator, miR-148b, and amplify their differentiation effect with miR-21.

Author Manuscript

The direct targets of miR148b and miR21 were extracted from microRNA.org, and the
relevant genes are summarized in Tables S3 and S4 in the Supporting Information. We
observe that NOG, an inhibitor of BMP-2, is a direct target of miR148b, and SOX2, a
pluripotency marker, is a target for miR21.[10–12]

Author Manuscript

For effective clinical use of miRNA mimic therapies, there is a need for targeted and precise
delivery of these small molecules for treatment to mitigate off-target effects and nonspecific
accumulation. There is also the need to protect the vulnerable nucleotide sequences from
intra and extra cellular nuclease degradation. In cases of bone defect repair and regeneration,
the need for spatial and temporal control was proven necessary as was demonstrated,[57]
in which the formation of uncontrolled heterotrophic bone growth from delivered BMPs in
other parts of the body became a clinical and health concern.

Author Manuscript

The miR-21/miR-148b-treated hASC groups listed in Table 1 were maintained at 37 °C
incubation for 21 days post-illumination prior to analysis, replenishing the stromal media
for all wells every 3 days. To assess mineralization between the different samples, two
chemical stain methods were used: xylenol orange (XO) and alizarin red (ARS). While the
latter is more common and replete in literature involving osteogenic assays, its nonspecific
binding to hydroxyapatite as well as lack of aqueous solubility has led to investigations
into alternative assays that can supplement the information provided by ARS, such as XO.
[58,59] XO is a calcium-binding stain, highly water soluble, nontoxic at low concentrations,
and fluorescent.[58] Accumulations of calcium deposits such as in mineralized nodules
produce intense orange fluorescence upon staining of those nodules. All hASC groups were
stained overnight with XO, and imaged after rinsing with Dulbecco’s phosphate-buffered
saline (DPBS). These results are presented in Figure 5. For the stromal culture medium
(SM) control group (A), only a diffusive light stain is observed, reflective of the lack of
mineralized nodules of these nondifferentiated hASCs. In the positive control group (C), in
which hASCs were left in osteogenic positive control (OM) for 21 days, high mineralization
was apparent with intense fluorescence in this sample. In groups E through I, in which
miR-21 and miR-148b were delivered to hASCs using SNPs and GNPs, respectively, small
mineralized nodule formations were evident. More intense stain was observed in groups H
and I, where the second miRNA (148b or 21) was delivered following a 48 h delay after the
Small. Author manuscript; available in PMC 2021 October 21.
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initial dose. Sporadic staining was evident in Group B, hASCs treated with GNPs-miR-148b
and SNPs-miR-21 but without photo-activation. This suggests some premature and random
cleaving of the miRNAs during incubation at 37 °C before their removal from media.
Remainder control groups and their images can be found in Figure S6 in the Supporting
Information.

Author Manuscript

To quantify the extent of mineralization of each sample, ARS was applied to
paraformaldehyde-fixed hASCs. All ARS images for all groups can be found in Figure S7 in
the Supporting Information. In Figure 5, the measured absorbances of ARS after de-staining
the samples, normalized to the number of hASCs, are shown. Groups with miR-21 and
miR-148b co-delivery regardless of sequence of delivery or duration, showed significantly
higher ARS than group A, the SM control. Group D which consisted of hASCs treated with
GNP-miR-148b only after 530 nm irradiation, yielded higher ARS than the SM group but
lower than the groups with both miRNAs delivered. The statistical differences at a 95%
or 90% confidence level between the groups, specifically the three negative controls, A
(SM), B (nonirradiated), and D (miR-148b), and the co-delivered groups are summarized in
Figure 5. Group C (OM), was statistically significant with respect to all groups with p-values
less than 0.001. To determine whether the increased mineralization effect of the combined
miRNAs was artifactual or real, osteogenic gene marker expressions were measured and
analyzed.

Author Manuscript

miR-148b has been demonstrated to upregulate alkaline phosphatase (ALP) activity de novo
in bone marrow-derived stem cells.[8] To evaluate ALP activity, all experimental groups
were measured for ALP gene expression at day 7, summarized in Figure 6. Group A (SM)
was used to normalize −ΔΔCt values, with 18 s used as the housekeeping gene. All treated
groups exhibited modest upregulation of ALP expression with respect to groups A and B.
While miR-148b alone displayed lower ALP upregulation than the other groups except B
(nonirradiated), no statistical significance at a 95% confidence level was found between
experimental groups at this stage.

Author Manuscript

At day 21, gene expression levels of Runx2, BMP-2, and osteopontin (OPN) were measured
to elucidate the osteogenic pathways of the different treatments. Runx2 is a mid-stage
marker and typically a strong indicator of osteogenesis in stem cells.[60] In Figure 7, group
C (OM) showed upregulation at this late time-point with −ΔΔCt mean of 2.25, and similar
upregulation for groups E–I. There was no determined statistical differences at a 95%
confidence level between the positive control and experimental groups, however, groups
H and I exhibited statistical differences at 90% confidence level with respect to group D.
Group D, with GNP-miR-148b only, displayed only modest upregulation compared to other
groups, with a mean −ΔΔCt value of 0.64.
OPN and BMP-2 are mid-to-late stage gene markers, and highly expressed in osteoblast
cells.[61] The gene expression results for OPN and BMP-2 displayed the most significant
results for the enhanced effect the co-delivery of miR-148b and miR-21 has on osteogenesis
(Figure 7). At this time point, groups E through I (miR-21 and 148b co-delivered)
all showed nonstatistical differences from group C (OM) for OPN expression, while
demonstrating statistical significance from groups D and B (148b only and nonirradiated)
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and robust upregulation with −ΔΔCt values ranging from 6.63 to 9.95 for the co-delivered
groups, compared to 2.31 for miR-148b alone. Among the co-delivered groups, delivery of
the miRNAs over a 48 h period (H and I) produced the most substantial and significantly
highest OPN upregulation. Interestingly, groups F through I, in which delivery of miRNA
mimics was performed sequentially over 24 or 48 h after the initial dose, showed statistically
higher expressions of BMP-2, with values ranging from 9.26 to 11.05, than even the
positive control group C with a reported value of 6.78. The gene expression results
provide compelling evidence for the potent effect of co-delivering miR-21 and miR-148b
on inducing an enhanced osteogenic pathway for hASCs.
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In examining Sox2 gene expressions at day 7, single release groups of either miR-148b
or miR-21 displayed downregulation of the potency marker, as predicted for cells
undergoing differentiation (Figure S10, Supporting Information). However, for all miR-21
and miR-148b co-delivered samples (groups E through I), Sox2 is shown to be significantly
upregulated. At day 21, this upregulation was amplified even more so, with −ΔΔCt values
reaching as high as 11 (Figure 7). Examination of the light-activated only group, presented
in Figure S11 in the Supporting Information, also demonstrated a modest increase in
Sox2 expression. One explanation is the possibility of induced toxicity post-irradiation that
might instigate cells to proliferate and regenerate. There have been reports of far-infrared
exposure causing upregulation of Sox2 gene expressions in hBMSCs.[62] The cell count
numbers for the different groups are also displayed in Figure 7 with a notable reduction
in cell numbers for some of the groups. These results may indicate the effect of miR-21
in arresting the cell cycle pathway and driving them toward a specific lineage. However,
the upregulation of Sox2 in groups E through I may also attest to a premature tumorigenic
growth response in these stem cells that may not be captured within the timeframe of
this study. Sox2 expression was positively correlated with cancer stem cells, specifically
in osteosarcomas.[63] Despite the lack of extensive proliferation seen from the cell number
trends, the occurrence of osteosarcomas will likely need to be validated in future in vivo
trials with extended differentiation profiles.

Author Manuscript

Overall, histochemical staining and polymerase chain reaction (PCR) results suggest the
co-delivery of miR-21 and miR-148b to have an increased effect on the osteogenic
differentiation of hASCs. While there exist some discrepancies on the extent of
mineralization and gene expressions between simultaneous delivery and sequential delivery
at different times and sequences, they were not significant enough to downregulate or nullify
miR-148b’s osteogenic ability, at least not within the time points selected for this study.
On the contrary, they all demonstrated enhanced faculty in this regard. The implications of
this suggest that, under a single dose of miR-21 and miR-148b conjugated to two different
nanoparticles, hASC osteogenesis can be upregulated with temporally discrete delivery of
the miRNA mimics. Interestingly, sequential delivery of the miRNA versus simultaneous
delivery did exhibit greater upregulation of osteogenic markers and mineralization,
significantly in some cases. This may be a result of overloading the RISC pathway during
simultaneous release, and hence diminishing the efficacy of miRNA targeting, or that the
fluctuating expressions of targeted genes and the delivery of miRNA mimics at 64 h
coincided with an ideal amount of expression for knockdown or upregulation. To rule out the
former hypothesis, miR-148b was delivered with an unrelated, anti-GFP siRNA. The data
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are presented in Figures S8 and S9 in the Supporting Information. No statistical upregulation
from miR-148b alone was observed for this group, but indeed showed identical trends to
the osteogenic ability of miR-148b alone. This strongly suggests that the enhancement in
osteogenesis was a result of miR-21 and miR-148b co-delivery. To eliminate the influence of
photo-induction at 64 h and other time points on osteogenic ability, different control groups
comprised of nonmodified nanoparticles light activated at serial time points mirroring the
main study are presented in Figure S13 in the Supporting Information, with gene expression
and mineralization assays. No statistical differences were observed between illuminations
at the distinct time points. However, a modest upregulation in Sox2 expression at day 21
was observed for all groups, which partly supports our hypothesis of the photothermal
effect inducing some self-renewal capacity in the hASCs. However, this effect was much
larger with the miRNAs delivered, which suggests a more intricate genetic effect on the
pluripotency profile of these cells.
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The presented model provides a working framework in which the delivery of two nucleic
acid therapies could be co-delivered at different time points with a single applied dose.
Complete staining assays and PCR results for chemically transfected miR-21 and 148b
mimics are presented in Figures S8 and S9 in the Supporting Information. Additionally,
the complete set of NP groups, including groups where both sets of NPs are present but
illuminated at only a single wavelength, and PCR results used in this study are presented
in Figures S10 and S11 in the Supporting Information. Cell counts of NP-transfected
and chemically transfected hASCs for each group by measuring DAPI (diamidino-2
phenylindole) intensities are presented in Figure S12 in the Supporting Information.
2.5.

Transfection and Uptake Efficiency

Author Manuscript

Transfection efficiencies measured by flow cytometry, and NP uptake efficiency measured
by inductively coupled plasma atomic emission spectroscopy (ICP-AES) are presented in
Figure S14 in the Supporting Information. Fluorescence measurements inside the cells
indicated SNP transfection at 40%, while GNP at 20% within 4 h after addition. The
low numbers are likely due to quenching effects on the fluorophore from the overlapping
nanoparticles ‘optical states during conjugation or degradation from exposure of the 5’
fluorophore to Rnase enzymes in subcellular compartments.

Author Manuscript

Using ICP-AES, SNPs uptake efficiency, calculated by normalizing the particle mass inside
cells to the total added, was determined to be 70.71 ± 2.14% at 16 h after transfection.
Meanwhile, 40 h after transfection that efficiency decreased to 48.57 ± 14.29% while
interestingly increasing again to 102.00 ± 5.00% after 64 h. These values suggest a role
of the uptake efficiency in improving osteogenesis, where groups in which the second
miRNA was released 64 h post-transfection showed the most dramatic results, possibly due
to increased intake of nanoparticles at this time point. In the closed environment of the 2D
cell cultures, the nanoparticles are likely undergoing exocytosis and re-entering cells during
the incubation cycles prior to media exchange.
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Raman Spectroscopy
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To determine the compositional nature of the mineralized nodules formed, Raman
spectroscopy was used to identify the unique vibrational modes of hydroxyapatite. In Figure
8, the peaks attributed to hydroxyapatite include the three minor peaks at 400–490, 570–
625, and 1020–1095 cm−1, and a single intense peak at around 960 cm−1.[64] Both OM
and miR-21/miR-148b samples displayed similar profiles to the hydroxyapatite sample,
particularly at the sole signature peak of 960 cm−1. These results give confidence that the
mineralization process was forming hydroxyapatite and not some other calcium salt as a
result of nonbone-related biomineralization. As a negative control, the SM group was tested
and displayed no hydroxyapatite crystal formation.

3.

Conclusion

Author Manuscript

A co-delivery system consisting of GNPs and SNPs systems was designed with the
ability to carry and photothermally release their miRNA payloads at distinct times and
wavelengths of light. Mineralization assays demonstrated higher staining with both miR-21
and miR-148b delivery, with increased gene expressions of Runx2, BMP-2, and OPN.
Herein, we demonstrated the potent ability of the retro-Diels–Alder chemistry to temporally
release genes and drive augmented osteogenesis in a single dose of our developed gene
therapy. Systems providing spatiotemporal control have the potential to improve outcomes
in surgical reconstruction and regenerative medicine by precise modulation of tissue repair
processes. Regulation of gene expression with miRNA mimics is a promising tool for
enhancing control of tissue repair processes particularly when combined with endogenous
MSC progenitors. Spatiotemporally directing the proliferation and osteogenic differentiation
of these progenitors is of particular interest in the design of therapies for segmental bone
defects, spinal fusion, and craniofacial reconstruction. The capability to target damaged
tissues selectively and modulate potency and osteogenic differentiation provides a clinically
relevant tool to stimulate osteogenic progenitors and improve segmental defect repair.
While the results presented suggest promise, further studies in vivo are needed to address
differences in diffusion, transfection efficiencies, and particle longevity in an active immune
system. We hope to investigate this further in future works.
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4.

Experimental Section

Materials:

Author Manuscript

6-Maleimidohexanoic acid (90%), 2-furanmethanethiol (98%), methanol (>99.9%),
isopropanol (>99.9%), dichloromethane (99.8%), N-hydroxysuccinimide (NHS, 98%), silver
nitrate (99%), formaldehyde (36.5–38%), sodium hydroxide (98%, pellets), HPC (Mn =
80 000, 99%), antifoam A (100%), tris(2-carboxyethyl) phosphine hydrochloride solution
(TCEP) (0.5 M), ARS staining solution (40 × 10−3 M), XO tetrasodium salt, glacial acetic
acid, and GNPs stabilized in 0.1 × 10−3 M PBS were purchased and used as received from
Sigma Aldrich (St. Louis, MO). EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride), Dulbecco’s modified Eagle medium/nutrient mixture F-12 (DMEM F-12),
DPBS without Ca/Mg, lipofectamine RNAiMAX transfection reagent, DEPC-treated water,
DAPI, transferrin from human serum/Texas Red conjugate and Opti-MEM reduced serum

Small. Author manuscript; available in PMC 2021 October 21.

Abu-Laban et al.

Page 13

Author Manuscript

medium were purchased from ThermoFisher Scientific (Waltham, MA), FBS from Lonza,
and hASCs at passage zero were acquired from LaCell (New Orleans, LA). Custom amine
modified oligonucleotides (miR-21: 3’ C6-NH2 2’OMe CAA CAC CAG UCG AUG GGC
UGU Cy3 5’; miR-148b: 5’ C6-NH2 2’OMe UCA GUG CAU CAC AGA ACU UUG U
6-FAM 3’; anti-GFP siRNA: 5’ GCAAGCUGACCCUGAAGUU 3’) were ordered from
Trilink Bio Technologies (San Diego, CA). Mounted 405 and 530 nm LED lights from
ThorLabs, Inc. (Newton, NJ) were used for photo-activation experiments.
Cell Culture:
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Commercially acquired hASCs from three different donors were cryopreserved at passage
0, and later thawed for subsequent use for in vitro experiments at passage 2. The cells
were passaged in 25 cm2 flasks (BD Falcon, Franklin Lakes, NJ) in SM, which consisted
of DMEM F-12, supplemented with 10% FBS and 1% antibiotic solution (10 000 μg
mL−1 with penicillin and streptomycin) at 37 °C and 5% CO2.[9] For the OM, SM
was supplemented with dexamethasone (1 × 10−9 M), ascorbic acid (50 × 10−6 M), and
β-glycerophosphate (20 × 10−3 M).
GNP and SNP Modification:
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HPC-SNPs were synthesized as described,[22,23] while PBS-stabilized, 80 nm diameter
GNPs were purchased from Sigma-Aldrich. To conjugate both sets of nanoparticles with
the miR-21 and miR-148b mimics, the surfaces were first conjugated with thiol- and
carboxyl-terminated Diels–Alder cycloadducts as outlined in Ref. [22]. In the present
study, miR-21 was coupled with silver, while miR-148b was coupled with gold. Briefly,
6-maleimidohexanoic acid (2.11 g) and 2-furanmethanethiol (0.5 g) were mixed in 20 mL
methanol and DCM (1:1) for 7 days. The linkers were then mixed with the nanoparticles at
approximately 8E9 particles per mL, in 1 mL aliquots for 24 h at room temperature to allow
for surface attachment through thiol linkage. For oligonucleotide addition, the nanoparticles
were first centrifuged (10 000 g, 10 min) and resuspended in isopropanol thrice, followed
by mixing with 100 × 10−3 M (100 μL) EDC/NHS and the respective 5’amine miRNA
mimics (4 × 10−6 M, 30 μL) for 24 h at room temperature to allow for covalent coupling.
Verification of conjugation was tested after centrifugation and resuspension in DEPC
water, by displacing the ligands with TCEP treatment (10 μL), and measuring supernatant
fluorescence at 525 nm for FAM, and 575 nm for Cy3.
Photothermal Release of Oligonucleotides:
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To test and compare the photothermal release rates of SNPs and GNPs, light irradiation
studies were set up. Equal concentrations (200 ppm) and volumes (100 μL) of each
conjugated nanoparticle were loaded separately into a 35 mm Petri dish, after which they
were irradiated at either 405 or 530 nm wavelength light. The measured power outputs for
each LED light source were reported as 570 mW at 405 nm, and 317 mW at 530 nm. The
irradiation times were selected to normalize the total energy at each wavelength. 25 μL
of each sample was used at each time point, and later collected, diluted, and spun down
to measure the supernatant fluorescence for either FAM or Cy3. All measurements were
normalized to a nonirradiated control as well as a TCEP-treated sample used to represent the
total particle loading. Additionally, zeta potential measurements of the nanoparticles were
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carried out to monitor the change in surface charge as the negatively charged molecules were
cleaved and removed.
SHG Measurement:

Author Manuscript

Nanoparticles for SHG measurements were prepared as follows: GNPs and SNPs were
prepared in colloidal aqueous suspension using chemical reduction of chloroauric acid
and silver nitrate, respectively.[19,20,65–67] All chemicals were purchased from Alfa Aesar
(Haverhill, MA) and used without further purification in ultrapure water. The colloidal
gold nanoparticle sample was prepared by a seeded-growth method using hydroquinone and
sodium citrate as reducing agents.[19,65,66] Briefly, an aqueous solution of 300 μL of 25 ×
10−3 M chloroauric acid in 30 mL of ultrapure water was brought to reflux under vigorous
stirring conditions, followed by the addition of 900 μL of 34 × 10−3 M sodium citrate to
synthesize gold seeds. The colloidal gold seed solution underwent a color change from pale
yellow to deep red after 15 min and was then removed from heating and cooled to room
temperature. For the seeded-growth synthesis of gold nanoparticles, 200 μL of prepared
gold seeds and 100 μL of 25 × 10−3 M chloroauric acid was added to 10 mL of water,
followed by the addition of 30 μL of 34 × 10−3 M sodium citrate, and 100 μL of 30 ×
10−3 M hydroquinone at room temperature under vigorous stirring conditions for 60 min.
For the silver nanoparticle synthesis, an aqueous solution was first made by mixing 250 μL
of 59 × 10−3 M silver nitrate, 1 mL of 34 × 10−3 M sodium citrate, 30 μL of 98 × 10−6
M potassium iodide, and 1.25 mL of ultrapure water. This solution was added to 100 μL
of 100 × 10−3 M ascorbic acid solution in 47.5 mL of boiling water and the mixture was
refluxed for 60 min under vigorous stirring conditions to prepare the silver nanoparticles.
[20,67] The nanoparticles were further modified with the Diels–Alder-linked miRNA mimics
as described above.
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The experimental setup for the SHG, which was consisted of an ultrafast laser system, an
optical setup, and a high-sensitivity spectroscopy detector, was described previously.[19,20,45]
A portion of the titanium:sapphire oscillator laser beam, centered at 800 nm with 75 fs
pulses at 80 MHz repetition rate and an average power of 2.6 W, was used to seed the
amplifier laser which pumped an optical parametric amplifier (OPA) for tunable-wavelength
laser light. The beam from the OPA was used for irradiation studies at 400 and 530 nm,
corresponding to the plasmon resonances of the SNPs and GNPs, respectively. For SHG
measurements, the remaining portion of the 800 nm oscillator laser was attenuated to
an average power of 790 mW and was focused to a 1 cm quartz cuvette containing the
nanoparticle sample. An integrated data acquisition program controlled a magnetic stir bar
and a beam block to open and shut every 20 s for collecting the SHG and background
spectra in order to measure the background-subtracted SHG signal as a function of time.
In Vitro Photo-Release of SNPs and GNPs:
To monitor the in vitro release of the fluorescently-labeled payload, hASCs were transfected
with each of the nanoparticles. For this experiment, the FAM fluorophore was used on
both nanoparticle sets. The hASCs were initially seeded at a density of 3 00 000 cells per
dish, on 35 mm glass-bottom Petri dishes in SM and incubated at 37 °C, 5% CO2. After
24 h, 100 uL each of the conjugated GNPs and SNPs were added separately to the cells
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for transfection and incubated for an additional 4 h. The groups tested included hASCs
with GNPs-FAM nonirradiated, SNPs-FAM nonirradiated, GNPs-FAM irradiated at 530
nm, GNPs-FAM irradiated at 405 nm, SNPs-FAM irradiated at 530 nm, and SNPs-FAM
irradiated at 405 nm. Three dishes were used for each group (NA/450 nm/530 nm), for each
nanoparticle set, gold and silver, with two images taken per dish for a total of 18 images
per set. The merged nanoparticle and fluorophore confocal images are presented in the main
text. Additional images, along with rotated z-stacks to highlight the de-localization of the
probes, are provided in Figure S5 in the Supporting Information.
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All cells treated with SNPs were additionally stained with the endosomal tracking agent
transferrin, tagged with Texas Red, as described in literature.[24,50] The transfected cells
were placed in Opti-MEM medium prior to LED irradiation. Cells were irradiated at the
405 nm LED light (50 J), and at 530 nm (565 J). Post-irradiation, the dishes were incubated
at 37 °C for an additional 4 h prior to imaging. The dishes were mounted in an Olympus
FV10i-LIV confocal microscope at objective 60X phase contrast water immersion/NA1.2.
SNPs-FAM samples were viewed at blue (405 nm/420–520 nm) and FITC (495 nm/519 nm)
channels, while GNPs-FAM samples were viewed at POPO-3 (533 nm/574 nm) and FITC
(495 nm/519 nm) channels.
The Manders coefficient was calculated using FIJI software. Initially, background
subtraction was run by selecting a background region of interest and subtracting it from
the image. Furthermore, the threshold was calculated prior to running the Coloc 2 plug-in in
FIJI. The threshold-accounted coefficients were used for reporting, specifically for the green
channel in which the fluorophore was imaged.
Osteogenic Induction:
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To assess the effect of co-delivering miR-21 and miR-148b on the osteogenic induction of
hASCs, 2 × 105 cells per well were seeded in 24-well tissue culture plates (BD Falcon,
Franklin Lakes, NJ). Prior to treatment, the hASCs were left to incubate in SM at 37 °C
for 24 h. A total of 13 groups in duplicates were set up to measure different effects of
sequence and dosage time, as well as controls. These are summarized in Table 1. Only
results for groups A through I are depicted in the main article, while comprehensive results
with the remaining four control groups can be found in the Supporting Information. Prior to
transfection, all groups to be irradiated were placed in Opti-MEM solution. For transfection,
5 μL of SNP-miR-21 (≈8E9 particles mL−1, 0.123 × 10−6 M miR-21) and/or 10 μL GNP
miR-148b (≈4E9 particles mL−1, 0.128 × 10−6 M miR-148b) suspended in Opti-MEM
were added to the respective groups for 16 h prior to photo-release. Where indicated, the
treated cells were exposed to 405 nm LED light (50 J), and/or 530 nm LED light (565
J). The cells were maintained in the same Opti-MEM at 37 °C in between the different
photo-release wavelengths, as well as for an additional 24 h after the final irradiation step,
prior to replacing media with SM. Thereafter, the culture media was replaced every 3 days
with SM. Evaluation of osteogenesis was conducted at day 7 and day 21 using PCR, and
histochemical staining at day 21.
For investigating the effect of the miRNAs alone, additional groups in which the miRNA
mimics were chemically transfected using RNAiMAX transfection reagent only, per the
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manufacturer’s protocol, were set up and are presented in the Supporting Information.
Included with this set was an unrelated anti-GFP control siRNA co-delivered with
miR-148b.
Histochemical Staining:
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To evaluate mineralization of the cultured cells after 21 days, ARS and XO staining were
conducted independently. In the latter case, the wells were rinsed with DPBS and fixed with
4% paraformaldehyde solution for 15 min at room temperature. They were then rinsed again
and stained with 40 × 10−3 M ARS staining solution for 20 min.[9] The dye was removed and
wells were washed with DPBS five times prior to imaging on an Olympus light microscope.
For quantification, 10% acetic acid was used for de-staining, as outlined in ref. [68]. Briefly,
200 uL of 10% acetic acid was added to each well, and incubated at room temperature for
30 min. The well contents were scraped and collected in microcentrifuge tubes, followed
by heating at 85 °C for 10 min. After leaving on ice for 5 min, the solid components were
centrifuged out, the supernatant collected and measured at 505 nm absorbance. All values
were normalized to the number of hASCs at day 21, measured by DAPI staining.
For XO staining, a 20 × 10−3 M stock solution was prepared, and transferred to the live cells
in SM at a final concentration of 20 × 10−6 M. The stained samples were left overnight for 24
h at 37 °C, prior to rinsing with DPBS and imaging.
Quantitative Real Time Polymerase Chain Reaction (qPCR):
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To measure gene expressions at day 7 and day 21, RNA was extracted from the hASCs
with PureLink RNA Mini Kit (Thermo Fisher), following the manufacturer’s protocol. The
extracted RNA was converted to cDNA prior to amplification using the Thermo Scientific
Verso cDNA Synthesis Kit, and running it on the QuantStudio 3 Real-Time PCR system.
For PCR amplification of the cDNA, the following primer sequences (Integrated DNA
Technologies, Coralville, IA) were used to assess osteogenic and pluripotent gene
expressions (forward and reverse): ALP, 5′-AATATGCCCTGGAGCTTCAGAA-3′ and 5′
CCATCCC-ATCTCCCAGGAA-3′; RUNX2, 5′-GCAAGGTTCAACGATCTGAGATT-3′
and 5′-AGACGGTTATGGTCAAGGTGAAA-3′; OPN, 5′-TTCCAAGTAAG
TCCAACGAAAG-3′ and 5′-GTGACCAGTTCATCAGATTCAT-3′; BMP-2, 5′
ACTACCAGAAACGAGTGGGAA-3′ and 5′-GCATCTGTTCTCGGAAAACCT-3′;SOX2,
5′-TACAGCATGTCCTACTCGCAG-3′ and 5′-GAGGAAG-AGGTAACCACAGGG-3′.
All genes were normalized to the 18s rRNA housekeeping gene and −ΔΔCt values were
calculated using the ΔΔCt method.[69]
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Transfection and Uptake Efficiency:
The transfection efficiency by fluorescence measurement was performed using flow
cytometry analysis. 4 h after transfection, the cells were trypsinized and fixed with
4%paraformaldehyde, and suspended in 96-well plates for analysis. Cy3-conjugated NPs
were used for all measurements. Red fluorescence of the cells was measured using BD
SORP LSRFortessa Cytometer (Franklin Lakes, NJ). 50 000 events were counted, with two
replicates used for each analyzed group. The percentage of hASCs transfected with either

Small. Author manuscript; available in PMC 2021 October 21.

Abu-Laban et al.

Page 17

Author Manuscript

Cy3-GNPs or Cy3-SNPs was determined using the phycoerythrin (PE) channel to view the
fluorophore, while FITC was used for NP plasmon scattering. The samples were run at a
flow rate of 0.5 μL s−1 and all analyses were performed using FlowJo software.
To measure the uptake of silver nanoparticles at the proposed illumination time points (16 h,
40 h, and 64 h), ICP-AES (Perkin Elmer Optima 5300 DV Optical Emission Spectrometer,
Walthon, MA), was used to measure silver quantities inside the cells. After fixation, the
cells were dehydrated overnight at 37 °C, and digested with 37% HCl solution. 7% diluted
samples were prepared for analysis.
Raman Spectroscopy:
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To empirically corroborate the hydroxyapatite identity of the mineralized nodules produced
by hASCs after 21 days, the following groups were prepared for Raman analysis: A, C, and
I, as well as commercial hydroxyapatite powder as a reference. The adhered hASCs were
detached and loaded onto a glass microscope slide in DPBS suspension prior to analysis.
A Horiba LabRam system was used for all measurements, using 488 nm laser and 50X
objective. The selected scan range used was 300–1200 cm−1.
Statistical Analysis:
Results presented were expressed as mean ± SEM, and analyzed by analysis of variance for
comparison of three or more groups, in which a p-value < 0.05, or 0.1 where indicated, was
deemed significant.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

A) TEM image and UV-vis spectra for silver nanoparticles, and B) gold nanoparticles.
C) Zeta potential measurements of miRNA-NP conjugates for silver and gold surfaces
with increasing doses of incident light. D) Normalized fluorescence measurements of
nanoparticle supernatant solutions, irradiated at 405 and 530 nm light wavelengths. Gold
nanoparticle surfaces in this experiment were modified with Diels–Alder-linked miRNA
mimic-FAM dye molecules, while silver nanoparticles were surface-modified similarly with
Cy3-tagged dye molecules.
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Figure 2.
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A) Representative SHG spectra of miRNA-functionalized silver nanoparticles at different
wavelengths and irradiation times. SHG intensity of the miRNA-functionalized gold and
silver nanoparticles as a function of time under varying laser irradiation powers using B) 530
nm and C) 400 nm. D) The obtained photothermal cleaving rate constants as a function of
laser power for miRNA-functionalized gold and silver nanoparticles, using 530 and 400 nm
irradiation, respectively.

Author Manuscript
Small. Author manuscript; available in PMC 2021 October 21.

Abu-Laban et al.

Page 22

Author Manuscript
Author Manuscript

Figure 3.

Colocalization of SNPs (blue) and conjugated FAM molecules (green) in hASCs. Irradiation
at 400 nm (50 J) and 530 nm (565 nm). 60X magnification used with scale bars annotated at
33 μm.
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Figure 4.

Colocalization of GNPs (red) and conjugated FAM molecules (green) in hASCs. Irradiation
at 400 nm (50 J) and 530 nm (565 nm). 60X magnification used with scale bars annotated at
33 μm.
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Figure 5.
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Xylenol orange stained samples, imaged 24 h after applied staining solution (top). All
images were collected at constant exposure conditions and magnification as indicated by
the scale bar set at 200 μm. (Bottom) Quantification of mineralization using Alizarin Red
S staining solution and p-value summary between three negative controls and experimental
groups. Values less than 0.05 are denoted as (*), and (**) for those less than 0.1, and X for
no statistical significance. The labels indicate the different samples as follows: A = Stromal
media control; B = miR-21-SNPs and miR-148b-GNPs without activation; C = Osteogenic
differentiation media control; D = miR-21-SNPs and miR-148b-GNPs, light activated at 405
and 530 nm wavelengths of light, simultaneously, 16 h after transfection; E = miR-21-SNPs
and miR-148b-GNPs, light activated at 405 nm 16 h post-transfection, followed by 530
nm at 40 h; F = miR-21-SNPs and miR-148b-GNPs, light activated at 530 nm 16 h post
transfection, followed by 405 nm at 40 h; G = miR-21-SNPs and miR-148b-GNPs, light
activated at 405 nm 16 h post-transfection, followed by 530 nm at 64 h; H = miR-21-SNPs
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and miR-148b-GNPs, light activated at 530 nm 16 h post-transfection, followed by 405 nm
at 64 h.
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Figure 6.
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Days 7 and 21 PCR results. ALP expression was measured at day 7, while Runx2, OPN,
and BMP-2 were measured at day 21. The legends indicate the different samples as follows:
B = miR-21-SNPs and miR-148b-GNPs without activation; C = Osteogenic differentiation
media control; D = miR148-GNPs light activated at 530 nm 16 h post-transfection; E
= miR-21-SNPs and miR-148b-GNPs, light activated at 405 and 530 nm wavelengths of
light, simultaneously, 16 h after transfection; F = miR-21-SNPs and miR-148b-GNPs, light
activated at 405 nm 16 h post-transfection, followed by 530 nm at 40 h; G = miR-21-SNPs
and miR-148b-GNPs, light activated at 530 nm 16 h post-transfection, followed by 405
nm at 40 h; H = miR-21-SNPs and miR-148b-GNPs, light activated at 405 nm 16 h
post-transfection, followed by 530 nm at 64 h; I = miR-21-SNPs and miR-148b-GNPs, light
activated at 530 nm 16 h post-transfection, followed by 405 nm at 64 h.

Small. Author manuscript; available in PMC 2021 October 21.

Abu-Laban et al.

Page 27

Author Manuscript
Author Manuscript

Figure 7.

Cell count number, measured by DAPI staining of cells, and Sox2 gene expression at
day 21. The legends indicate the different samples as follows: B = miR-21-SNPs and
miR-148b-GNPs without activation; C = Osteogenic differentiation media control; D =
miR148-GNPs light activated at 530 nm 16 h post-transfection; E = miR-21-SNPs and
miR-148b-GNPs, light activated at 405 and 530 nm wavelengths of light, simultaneously, 16
h after transfection; F = miR-21-SNPs and miR-148b-GNPs, light activated at 405 nm 16
h post-transfection, followed by 530 nm at 40 h; G = miR-21-SNPs and miR-148b-GNPs,
light activated at 530 nm 16 h post-transfection, followed by 405 nm at 40 h; H = miR-21
SNPs and miR-148b-GNPs, light activated at 405 nm 16 h post-transfection, followed by
530 nm at 64 h; I = miR-21-SNPs and miR-148b-GNPs, light activated at 530 nm 16 h
post-transfection, followed by 405 nm at 64 h.
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Figure 8.

Raman spectroscopy results for Groups A (SM), C (OM), and I (SNP-miR-21 and
GNP-148b) with hydroxyapatite powder used as a reference.
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hASC groups treated with GNP-miR-148b and/or SNP-miR-21, illuminated at different wavelengths.
Group

Description

A

hASCs in stromal medium (SM) only

B

hASCs transfected with SNP-miR-21 and GNP-miR-148b, but nonirradiated

C

hASCs in osteogenic differentiation medium (OM)

D

hASCs transfected with GNP-miR-148b only, and irradiated at 530 nm

E

hASCs transfected with SNP-miR-21 and GNP-miR-148b, and irradiated at 405 and 530 nm 16 h post-transfection

F

hASCs transfected with SNP-miR-21 and GNP-miR-148b, and irradiated at 405 nm at 16 h and 530 nm at 40 h

G

hASCs transfected with SNP-miR-21 and GNP-miR-148b, and irradiated at 530 nm at 16 h and 405 nm at 40 h

H

hASCs transfected with SNP-miR-21 and GNP-miR-148b, and irradiated at 405 nm at 16 h and 530 nm at 64 h

I

hASCs transfected with SNP-miR-21 and GNP-miR-148b, and irradiated at 530 nm at 16 h and 405 nm at 64 h

LA

Author Manuscript

miR-21 + 405nm

hASCs transfected with nonmodified SNPs and GNPs, and irradiated at 405 and 530 nm at 16 h
hASCs transfected with SNP-miR-21 only, and irradiated at 405 nm

miR-21 + miR-148b +
405nm

hASCs transfected with SNP-miR-21 and GNP-miR-148b, and irradiated at 405 nm only

miR-21 + 148b + 530nm

hASCs transfected with SNP-miR-21 and GNP-miR-148b, and irradiated at 530 nm only
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